{
    "2021-04-08": [
        [
            {
                "time": "",
                "original_text": "高瓴资本概念股整体强势，凯莱英、健帆生物、国瓷材料领涨",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "概念股",
                        "凯莱英",
                        "健帆生物",
                        "国瓷材料",
                        "领涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物(300529)：快速成长的血液灌流龙头",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "血液灌流",
                        "龙头"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：医疗体系运行常态化 看好一季度业绩表现",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医疗体系",
                        "常态化",
                        "一季度",
                        "业绩表现"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}